Severe thrombocytopaenia secondary to COVID-19

BMJ Case Reports - Tập 13 Số 9 - Trang e237645 - 2020
Trupesh Patel1, Noah J. Stanton1, Ioannis Gkikas2, Diana Triantafyllopoulou3
1Department of Medicine, Royal Blackburn Teaching Hospital, Blackburn, Lancashire, UK
2Gastroenterology, Royal Blackburn Teaching Hospital, Blackburn, Lancashire, UK
3Haematology, Royal Blackburn Teaching Hospital, Blackburn, Lancashire, UK

Tóm tắt

The SARS-CoV-2 infection has caused a pandemic with a case rate of over 290 000 lab-confirmed cases and over 40 000 deaths in the UK. There is little evidence to inform the optimal management of a patient presenting with new or relapsed acute idiopathic thrombocytopaenic purpura with concurrent SARS-CoV-2 infection. We present a case of severe thrombocytopaenia complicated by subdural haematoma and rectal bleed associated with COVID-19. A 67-year-old man, admitted with a non-productive cough and confusion, was found to be positive for COVID-19. Ten days after admission, his platelets decreased from 146×109/L to 2×109/L. His platelets did not increase despite receiving frequent platelet transfusions. He was non-responsive to corticosteroids and intravenous immunoglobulins. Romiplostim and eltrombopag were given and after 9 weeks of treatment, his platelet count normalised. He was deemed medically fit with outpatient follow-up in a haematology clinic.

Từ khóa


Tài liệu tham khảo

GOV.UK . Coronavirus (COVID-19) in the UK. Available: https://coronavirus.data.gov.uk/ [Accessed 10 Jun 2020].

McGonagle, 2020, Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia, Lancet Rheumatol, 2, e437, 10.1016/S2665-9913(20)30121-1

Pavord, 2020, Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic, Br J Haematol, 189, 1038, 10.1111/bjh.16775

Zulfiqar, 2020, Immune thrombocytopenic purpura in a patient with covid-19, N Engl J Med, 382, e43, 10.1056/NEJMc2010472

Lévesque V , Carrier FM , Corsilli D , et al . Severe immune thrombocytopenic purpura in critical COVID-19: a case report. Int J Hematol 2020:1–5.

10.1001/jama.2020.2648

Magdi, 2019, Severe immune thrombocytopenia complicated by intracerebral haemorrhage associated with coronavirus infection: a case report and literature review, Eur J Case Rep Intern Med, 6

Neunert, 2019, American Society of hematology 2019 guidelines for immune thrombocytopenia, Blood Adv, 3, 3829, 10.1182/bloodadvances.2019000966

Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032

Italiano JE , Hartwig JH . Megakaryocyte development and platelet formation. In: Platelets in thrombotic and Non-Thrombotic disorders. New York: Springer, 2007: 39–53.

Behnke, 1998, From megakaryocytes to platelets: platelet morphogenesis takes place in the bloodstream, Eur J Haematol Suppl, 61, 3, 10.1111/j.1600-0609.1998.tb01052.x

Aschoff L . Über capilläre Embolie von riesenkernhaltigen Zellen. Virchows Arch Pathol Anat und Physiol Klin Med 1893;134.

10.1097/00000441-196609000-00009

10.1111/j.1600-0609.1993.tb00637.x

10.1146/annurev-physiol-030212-183752

10.1038/nature21706

Xu, 2020, Mechanism of thrombocytopenia in COVID-19 patients, Ann Hematol, 99, 1205, 10.1007/s00277-020-04019-0

Yang, 2005, Thrombocytopenia in patients with severe acute respiratory syndrome (review), Hematology, 10, 101, 10.1080/10245330400026170

Gang, 2003, Variation in the titer of the specific IgG antibody in patients with SARS, J Trop Med, 3, 283

Bomhof, 2020, COVID-19-associated immune thrombocytopenia, Br J Haematol, 190, e61, 10.1111/bjh.16850

World Health Organization . Who clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Available: https://apps.who.int/iris/handle/10665/331446 [Accessed 10 Jun 2020].

10.1164/rccm.201706-1172OC

Catalá-López, 2015, Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: systematic review and meta-analysis of randomized controlled trials, Med Clin, 145, 511, 10.1016/j.medcli.2015.03.014